ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Stem Cells in the City 2017 – Gotham Magazine

Continue reading

2017-05-04 Michael Zand NEWS

Doctors Excited By Results Of New Immunotherapy Cancer Treatment – CBS Pittsburgh / KDKA


Gotham Magazine

Stem Cells in the City 2017
Gotham Magazine
The New York Stem Cell Foundation (NYSCF) Research Institute Junior Leadership Council (JLC) hosted its 5th annual reception on Wednesday, April 26, 2017 at The Attic in midtown, to help raise awareness and funds for NYSCF. The JLC’s mission is to …

Continue reading

2017-05-04 Michael Zand NEWS

The FDA grants CD33-specific CAR+ T cell Investigational New Drug Application clearance for treatment of R/R AML – AML Global Portal

The FDA grants CD33-specific CAR+ T cell Investigational New Drug Application clearance for treatment of R/R AMLAML Global PortalOn 2nd May 2017, the U.S. Food and Drug Administration (FDA) accepted the Investigational New Drug (IND) application and gr… Continue reading

2017-05-04 Michael Zand NEWS

Preclinical Data from REGENXBIO RGX-314 Gene Therapy Program for Wet Age-Related Macular Degeneration to be … – Nasdaq


The Sun

Doctors Excited By Results Of New Immunotherapy Cancer Treatment
CBS Pittsburgh / KDKA
“Since December, there have been data presented showing that the immunotherapy actually works in about a third of lung cancer patients, and it works better than chemo,” Dr. Finley said. “For us, it’s just something we’ve never seen before, and we’re …
What is immunotherapy, how much does the cancer treatment cost and how could Bradley Lowery be helped by it?The Sun
Researchers identify immunotherapy targets in early-stage lung cancerMedical Xpress
Influenza vaccine may cause exaggerated immune response in patients on cancer immunotherapyThe Pharmaceutical Journal

all 6 news articles »

Continue reading

2017-05-04 Michael Zand NEWS

Preclinical Data from REGENXBIO RGX-314 Gene Therapy Program for Wet Age-Related Macular Degeneration to be … – GlobeNewswire (press release)

Preclinical Data from REGENXBIO RGX-314 Gene Therapy Program for Wet Age-Related Macular Degeneration to be …
Nasdaq
ROCKVILLE, Md., May 04, 2017 (GLOBE NEWSWIRE) — REGENXBIO Inc. (Nasdaq:RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV® Technology …

and more »

Continue reading

2017-05-04 Michael Zand NEWS

University of Zurich Team Profiles Immune Landscape in Kidney Cancer – GenomeWeb

Nature.comUniversity of Zurich Team Profiles Immune Landscape in Kidney CancerGenomeWebThe data provides insight into the basic biology of patient immune function in ccRCC, while also identifying markers that could be useful for guiding immunotherapy t… Continue reading

2017-05-04 Michael Zand NEWS

What is immunotherapy, how much does the cancer treatment cost and how could Bradley Lowery be helped by it? – The Sun

Preclinical Data from REGENXBIO RGX-314 Gene Therapy Program for Wet Age-Related Macular Degeneration to be …
GlobeNewswire (press release)
ROCKVILLE, Md., May 04, 2017 (GLOBE NEWSWIRE) — REGENXBIO Inc. (Nasdaq:RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV® Technology …

and more »

Continue reading

2017-05-04 Michael Zand NEWS

‘Second genetic code’ edited in stem cells to study disease-causing changes – The San Diego Union-Tribune


The Sun

What is immunotherapy, how much does the cancer treatment cost and how could Bradley Lowery be helped by it?
The Sun
A PIONEERING cancer treatment that “weaponises” the body’s immune system has been labelled as “breakthrough” in the fight against cancer. Immunotherapy targets defensive T-cells, and modifies them to seek out and destroy cancer, but how exactly does …

and more »

Continue reading

2017-05-04 Michael Zand NEWS
  • 1
  • …
  • 1,764
  • 1,765
  • 1,766
  • 1,767
  • 1,768
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

The San Diego Union-Tribune

‘Second genetic code’ edited in stem cells to study disease-causing changes
The San Diego Union-Tribune
The Salk Institute-led study demonstrated how to do this, creating stem cells that reliably pass along their modified epigenomes to descendant cells, and to mature cells produced from them. They used a widely occurring epigenetic process called …